MUSTANG BIO INC (MBIO) Stock Income Statement
NASDAQ:MBIO - Nasdaq - US62818Q3020 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 7.57M | 12.31M | 50.47M | 76.16M | 66.72M | |||
| Research and Development | 3.15M | N/A | 39.14M | 61.25M | 53.51M | |||
| Selling, General, and Administrative Expenses | 3.92M | 4.14M | 9.69M | 12.21M | 11.02M | |||
| Operating Income | -7.57M | -12.31M | -50.47M | -76.16M | -66.72M | |||
| Interest Income/Expense | 239.00K | N/A | -3.26M | -2.67M | 350.00K | |||
| Other Income/Expense | N/A | 310.00K | 920.00K | 1.30M | N/A | |||
| Non Recurring Items | N/A | -3.69M | 1.47M | N/A | N/A | |||
| Income Before Taxes | -10.71M | -16.00M | -52.00M | -77.53M | -66.37M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -10.71M | -16.00M | -52.00M | -77.53M | -66.37M | |||
| EBITDA | -7.15M | -11.64M | -48.61M | -73.44M | -64.55M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.38 | -26.24 | -6.04 | -11.24 | -11.33 | |||
| Non GAAP EPS | N/A | N/A | -316.00 | -562.50 | -570.00 | |||
| Statistics | ||||||||
All data in USD